BROMOCRIPTINE IN THE TREATMENT OF PARKINSONS-DISEASE

被引：0

作者：

GODWINAUSTEN, RB

机构：

来源：

SCOTTISH MEDICAL JOURNAL | 1980年 / 25卷

关键词：

D O I：

10.1177/003693308002500448

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S61 / S64

页数：4

共 12 条

[1]

CALNE DB, 1974, LANCET, V2, P1355

[2] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].

CORRODI, H ;

FUXE, K ;

HOKFELT, T ;

LIDBRINK, P ;

UNGERSTEDT, U .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412

[3] EFFECT OF CB-154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSSOVER TRIAL [J].

GERLACH, J .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (03) :189-200

[4]

GODWINAUSTEN RB, 1969, LANCET, V2, P165

[5]

GODWINAUSTEN RB, 1974, BRIT J CLIN PHARMACO, V1, P417

[6]

KARTZINEL R, 1976, LANCET, V2, P272

[7] BROMOCRIPTINE IN PARKINSONISM - LONG-TERM STUDY [J].

LEES, AJ ;

HADDAD, S ;

SHAW, KM ;

KOHOUT, LJ ;

STERN, GM .

ARCHIVES OF NEUROLOGY, 1978, 35 (08) :503-505

[8]

LUDIN HP, 1978, LANCET, V2, P578

[9]

LUDIN HP, 1976, NERVENARZT, V47, P655

[10] BROMOCRIPTINE TREATMENT IN PARKINSONS-DISEASE [J].

PARKES, JD ;

MARSDEN, CD ;

DONALDSON, I ;

GALEADEBONO, A ;

WALTERS, J ;

KENNEDY, G ;

ASSELMAN, P .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (02) :184-193

← 1 2 →